Prev Next

Heberprot-P Treatment Benefits Thousands in Cuba

15-05-2017 Hits:114

Heberprot-P Treatment Benefits Thousands in Cuba

More than 65 000 patients from all over Cuba have so far received the benefits of Heberprot-P, a drug first used on June, 2007, during a pilot study in the island’s central province of Sancti Spiritus. The medication, created by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB), is the only product in the world for the treatment of diabetic foot ulcers in advanced stages since it accelerates the healing of the lesions and significantly reduces the risk of amputation of the lower limbs. Sancti Spiritus Outstanding in Heberprot-P Treatment Actions Heberprot-p is registered in more than 20 nations, and has a patent awarded with the Gold Medal of the World Intellectual Property Organization (WIPO). Nearly 250 000 from around the world have been favoured with this terapeutic solution, the first with effective results ever. Iris Lugo, communication specialist at CIGB, told Granma that next May 11-12, the Havana’s Riviera Hotel...

Medical directors of the INTERMED Hospital in Ulaanbaatar meet with Cuban Ambassador.

30-03-2017 Hits:251

Medical directors of the INTERMED Hospital in Ulaanbaatar meet with Cuban Ambassador.

Ulaanbaatar. March 30, 2017. (EmbaCuba Mongolia) Cuban Ambassador Raúl Delgado held a working meeting with the Executive Director (CEO) of the INTERMED Hospital Sr. Ya.Nyamtogtokh, as well as with the main executives and chiefs of medical specialties of that prestigious hospital In Ulaanbaatar the capital of Mongolia.   The doctors were able to know through the presentation offered by the Cuban Ambassador of the excellent medicines that are produced in the Center of Genetic Engineering and Biotechnology of Cuba. At the meeting INTERMED specialists were interested in several of the drugs presented which are already marketed by the CIGB in 50 countries with which Cuba has cooperative relations. Specialist medical services were also part of the interest of Mongolian professionals who praised the development of medicine in Cuba and scientific advances in the care of diseases such as diabetes, hepatitis and cancer.

Signed in Mongolia Letter of Intent for the use of Cuban biotech products.

17-03-2017 Hits:370

Signed in Mongolia Letter of Intent for the use of Cuban biotech products.

Ulaanbaatar. March 16, 2017. With the presence of the Minister of Health, Dr. A.Tsogtsetseg, a Letter of Intent was signed this morning between the Center for Genetic Engineering and Biotechnology (CIGB) of Cuba and the Central Hospital No. 1 of Mongolia which reflects the intention of both institutions to promote medical programs and therapies based on Cuban biotechnological medicines. The document was signed by the Cuban side by Dr. Eulogio Pimentel, Director of the Center for Genetic Engineering and Biotechnology, and by the Mongolian side the General Director of Central Hospital No. 1, Dr. Byambadorj Batsuuri. During the ceremony the Minister of Health noted that the visit of the CIGB delegation, by invitation of the President of Mongolia, has motivated in the health sector and pharmaceutical companies a great interest in the use of the products and therapies proposed by Cuban specialists. Cuban Ambassador, Raúl Delgado Concepción, said that visits to...

New treatment for diabetic foot ulcers launched in Kuwait

10-03-2017 Hits:329

New treatment for diabetic foot ulcers launched in Kuwait

The Heberprot-P, a developed treatment for diabetic foot ulcers, recently registered in Kuwait, was launched by the Center for Genetic Engineering and Biotechnology (CIGB) in coordination with Kuwait's Central Gulf Medical Company (CGMC) at the Hotel Mövenpick on 6 March. The launch ceremony was attended by Dr. Eulogio Pimentel Vázquez, General Director of CIGB, who outlined the development of Cuba in the field of biotechnology, and detailed the products that have contributed to the diagnosis, prevention and treatment of many diseases, and their impact on health, agriculture and the environment. Dr. Jorge Berlanga, creator of Heberprot P and Dr. José Ignacio Fernández Montequín of the Institute of Angiology and Vascular Surgery of Cuba offered extensive information on Heberprot-B, noting that its characteristics and effects make it the only therapeutic alternative for the deep and complex ulcers suffered by diabetics. He added that the treatment also reduced the risk of limb amputation and...

Sancti Spiritus First to Use Herberferon in Cuba

07-02-2017 Hits:467

Sancti Spiritus First to Use Herberferon in Cuba

According to the latest statistical records, skin cancer —the one with the highest incidence in the territory in recent years—  continues to rise rapidly in Sancti Spiritus Sancti Spíritus becomes the first Cuban territory to use Heberferon, a drug created by the Center of Genetic Engineering and Biotechnology (CIGB) to fight skin cancer, after the results obtained in the clinical trials which led to the cure or remission of the disease in several groups of patients. According to the latest statistical records, skin cancer —the one with the highest incidence in the territory in recent years—  continues to rise rapidly in this province, where more than 3 600 cases have been reported. The product was first used at the provincial hospital about a year and a half ago as a clinical phase IV trial and was then introduced in one of the local polyclinics. It is administered as an intratumoral and perilesional injection...

Heberprot-P registered in 23 countries

06-09-2016 Hits:1826

Heberprot-P registered in 23 countries

Ten years after receiving its health registration and approval to be used in the national health system, the medicine Heber¬prot-P has been used to treat over 55,000 Cuban patients nationwide, with positive results Ten years after receiving its health registration and approval to be used in the national health system, the medicine Heber­prot-P has been used to treat over 55,000 Cuban patients nationwide, with positive results. Developed by a team of experts led by Dr. Jorge Berlanga Acosta from the Center for Genetic Engineering and Biotechnology (CIGB), Heber­prot-P is an injectable medication used to treat advanced foot ulcers in diabetic patients by accelerating the healing process, thus reducing the risk of amputation in over 78% of cases. The only one of its kind in the world, the product received the Gold Medal awarded by the World Intellectual Property Organization (WIPO) and offers a novel therapeutic solution to a condition which previously lacked effective...

Cuba registers new skin cancer medicine

06-09-2016 Hits:1138

Cuba registers new skin cancer medicine

Cuba has registered a new skin cancer medicine called “Heberferon” developed by the island’s Genetic Engineering and Biotechnology Center (CIGB) After 20 years of research and clinical trials, Cuba’s Havana-based Genetic Engineering and Biotechnology Center (CIGB) has developed a new medicine called “Heberferon.” BiologistIraldo Bello, who participated in the process, described the drug which combines interferón “Alfa” and interferón “Gamma” through the use of recombinant technology at the CIGB - as “unique” in the world.  The injectable medication cures or reduces the size of malignant skin tumors and can prevent scaring from surgery in areas difficult to operate on such as the face, noted the specialist.  Bello also explained that Cuba has a high rate of skin cancer, which is usually caused by excessive exposure to the sun. CIGB production plants have already manufactured over 10,000 vials of the new medicine, which continues to be developed with the aim of treating other types of cancer....

Want to Improve the Health of Millions of Americans? Lift the Embargo on Cuba

06-08-2015 Hits:2724

Want to Improve the Health of Millions of Americans? Lift the Embargo on Cuba

By reopening embassies, removing Cuba from the “terror list” and making it a bit easier for Americans to travel there, President Barack Obama’s White House has taken initial steps to put an end to a policy that has adversely affected the health of the American people for over half a century. The Senate Appropriation Committee’s action last week to even further ease restrictions on travel to Cuba by U.S. citizens and relax some provisions of the economic embargo, is welcome for a variety of reasons, but perhaps most urgently for the health of citizens in both countries. Forty years ago, when Jimmy Carter lifted the then-total ban on Americans traveling to Cuba, it became very clear to me as an adviser on health policy to the president, that no element of our two societies would benefit more from the free exchange of ideas than the health of our two peoples.  The announcement...

Cuba’s flag flies in Washington

06-08-2015 Hits:2669

Cuba’s flag flies in Washington

Washington, D.C — In a ceremony attended by some 500 invited guests on July 20, the Cuban flag was raised over the Cuban Embassy in Washington, D.C., for the first time since 1961, when U.S. imperialism broke relations between the two countries. Other supporters successfully fought back right-wing forces who tried to disrupt the event. Bruno Rodríguez Parrilla, foreign affairs minister of Cuba, told those gathered: “The flag that we revere … is the same that was hauled down here 54 years ago, which was zealously kept in Florida by a family of liberators and later on by the museum of our eastern city of Las Tunas, as a sort of premonition that this day would certainly come. “Flying once again in this place is the lone-star flag which embodies the generous blood that was shed, the sacrifices made and the struggle waged for more than 100 years by our people for their...

As Cuba-US Relations Thaw, Potential Medical Advances Grow

13-07-2015 Hits:3030

As Cuba-US Relations Thaw, Potential Medical Advances Grow

Recent US steps toward normalizing relations with Cuba after 5 decades may open doors in both countries to medical advances. In December 2014, President Obama reestablished diplomatic relations and eased travel restrictions. In April of this year, Congress removed Cuba from its terror list, and this month, the two countries are expected to resume diplomatic relations and reopen embassies in both countries. Mark Rasenick, PhD, professor of physiology, biophysics, and psychology and director of the biomedical neuroscience training program in the University of Illinois at Chicago College of Medicine, travels to Cuba at least once a year and has testified before Congress on medical partnership possibilities. He told Medscape Medical News that some collaborations will be seen very soon, but new treatments and products will be available only if and when the trade embargo is lifted. One area in which Cuba can contribute expertise is brain mapping, Dr Rasenick said. Because widespread magnetic resonance...

Happy Anniversary 58 of the Triumph of the Revolution

 
   
 
Vinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo Slider
   
 

Promotion to Events

CIGB Biotecnología Cubana

Heberprot-P. A safe and effective treatment

Social Networks

Facebook Twitter Yotube 

Other Areas

Visit

2876642
Today
Yesterday
Thiis Week
Last Week
This Month
Last Month
All
2320
1801
16696
2842368
69246
57555
2876642